Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 2004

View Archived Issues

R&D highlights from the 4th Annual Biotech In Europe Investor Forum: Glycart

Bio-E-Gel shows efficacy in the management of vasomotor symptoms after menopause

New triptolide analogues presented by Pharmagenesis

Novel trimeric contrast agents designed at Schering AG

Pfizer researchers design new protein kinase inhibitors

Tibotec describes two series of anti-HIV agents

Two series of SERMs claimed by Merck scientists

New alpha7-selective nAChR ligands identified at NeuroSearch

New melanocortin MC4 receptor ligands and their use reported by SCRAS

New p38 kinase inhibitors developed by Uriach team

Dade Behring, U. of Frankfurt and Innovectis sign cardiac marker agreement

Phase I study for INSM-18 in relapsed prostate cancer patients

Roche signs for rights to Japan Tobacco's CETP inhibitor JTT-705

Corlux enters second pivotal study for psychotic major depression

Oncolytics Biotech reports on Reolysin

PDI to promote Shionogi's Cedax

New HSS antiviral guidelines for influenza cite Tamiflu

Initial research milestone in Kinexis/Merck & Co. collaboration

Complete response submitted for Combidex

European regulatory application filed for Procleix Ultrio on Tigris system

Alefacept approved in Canada for chronic plaque psoriasis

One-year results of the MOBILE study on ibandronate in osteoporosis

Nonsteroidal SARM shows potential for osteoporosis

A testosterone patch improves sexual functioning in postmenopausal women with HSDD

Clinical evidence for the efficacy of pregabalin in GAD

Merck researchers elucidate tissue selective agonism of SARM SA-766

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...